Aims and Scope
The Journal will publish high-quality peer-reviewed articles addressing most aspects of therapeutic, molecular and biochemical research on venoms . The Journal aims at providing an efficient route to fast-track publication, within 10-12 weeks of manuscript submission if accepted. Furthermore, manuscripts will be made available online in their final form generally within 2-3 weeks of final acceptance.
The Journal will be primarily published online but on sufficient demand for printed version journal hard copies may also be provided to individuals and institutions.
Manuscripts in the following categories will be considered for publication: reviews, mini-reviews, research articles, research reports, research letters, clinical reports, case studies, new methods and technologies, meeting reports and commercial, patent and product news, and editorials (inquiries to the Editor).
Submission of a manuscript to the Journal implies that no part of the manuscript has been previously published in any language in a permanent archive, or the whole manuscript or any part of the manuscript is being considered for publication by another journal, or it violates anyone’s copyrights or any other rights. Reproduction of tables and figures from previously published articles must accompany written permission from the copyright holder(s) and should be provided at the time of manuscript submission. Submission of preliminary or inconclusive data is strongly discouraged. However, authors reporting high-impact conclusive preliminary data leading to the opening of new research fields are welcomed. Authors must also submit any closely-related manuscripts in press or submitted for publication to another journal. The corresponding author is responsible for obtaining permission of manuscript submission from all co-authors, and for ensuring that all co-authors are in complete agreement with the contents of the manuscript and its authorship. It is also assumed that authors have complied with all ethical and privacy guidelines and/or legislation concerning the submitted work – particularly related to the use of human or animal subjects and cloning research. If the work is multidisciplinary, all collaborators must ensure that they have appropriate measures in place to check the accuracy of their part of the data. The corresponding/senior author has the overall responsibility for the accuracy of the data presented in the manuscript. However, each author also has direct responsibility for the contents of the paper. Editors have the right to accept or reject an article, solely on merit.
Submission of a manuscript to the Journal implies that the author(s) fully agree to and understand the terms and conditions, and accept the policies of the Journal described under the Information for Authors at the time of manuscript submission.
Publication in the Journal implies that authors are prepared to provide, at reasonable costs, on request any reported strains, cell line, clones, molecules, etc., developed in their laboratories that are not commercially available, to colleagues in other academic, medical and non-profit research institutions.
Authors may also consult the uniform guidelines on the various ethical issues, the use of units of measurement, abbreviations and symbols, etc., set out by the International Committee of Medical Journal Editors on http://www.icmje.org.